Co-D Therapeutics is a preclinical stage biopharmaceutical company based in Madison, Wisconsin. The company engages in drug development dedicated to developing first-in-class combination nano-medicines with high safety profiles to treat cancer.
Company (Alive / Active)
316 West Washington Avenue
Wisconsin, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)